Honroth joins the board of directors alongside his new executive responsibilities. The appointment follows Clemmer’s tenure, which began in April 2016 when he first took the reins of the company. To ensure continuity during the shift in management, Clemmer will remain with the organization in a consulting capacity for an unspecified period. This move signals a strategic change in leadership as the firm looks to its next phase of operations under new guidance.
Eric Honroth Takes Helm at AngioDynamics
After a decade of leadership at AngioDynamics, chief executive James Clemmer is stepping down, marking a significant transition for the Latham-based medical technology firm. His successor, Eric Honroth, formerly the global president of life science at the Swedish company Getinge, steps into the role on November 2.
Comments (0)
No comments yet. Be the first!